Rickets News and Research

RSS
Rickets is a condition that causes children to have soft, weak bones. It usually occurs when children do not get enough vitamin D, which helps growing bones absorb important nutrients. Vitamin D comes from sunlight and food. Skin produces vitamin D in response to the sun's rays. Some foods also contain vitamin D, including fortified dairy products and cereals, and some kinds of fish.
Raptor initiates enrollment in pivotal Phase 3 clinical trial of DR Cysteamine for nephropathic cystinosis

Raptor initiates enrollment in pivotal Phase 3 clinical trial of DR Cysteamine for nephropathic cystinosis

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

SciMed Technologies receives certification for VitaKit A from AOAC International

SciMed Technologies receives certification for VitaKit A from AOAC International

Vitamin D plays much wider role in people's life

Vitamin D plays much wider role in people's life

Pregnant Arab women have high prevalence of vitamin D deficiency: Study

Pregnant Arab women have high prevalence of vitamin D deficiency: Study

Enobia Pharma unveils findings from first HPP self-reported patient survey at ACMG 2010

Enobia Pharma unveils findings from first HPP self-reported patient survey at ACMG 2010

You and your baby may need vitamin D supplementation says research

You and your baby may need vitamin D supplementation says research

McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseases

McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseases

Raptor Pharmaceutical to present DR Cysteamine trial data at Lysosomal Disease Network Symposium

Raptor Pharmaceutical to present DR Cysteamine trial data at Lysosomal Disease Network Symposium

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Vitamin D: A multi-purpose nutrient for overall health

Vitamin D: A multi-purpose nutrient for overall health

Raptor Pharmaceutical announces Phase 2b results of DR Cysteamine trial

Raptor Pharmaceutical announces Phase 2b results of DR Cysteamine trial

Common myths about sun exposure, sunscreen and vitamin D

Common myths about sun exposure, sunscreen and vitamin D

Enobia Pharma initiates study of bone-targeted enzyme replacement therapy for hypophosphatasia

Enobia Pharma initiates study of bone-targeted enzyme replacement therapy for hypophosphatasia

Individualized MicroNutrient Testing for patients

Individualized MicroNutrient Testing for patients

Millions of children in the US suffer from suboptimal levels of vitamin D

Millions of children in the US suffer from suboptimal levels of vitamin D

Parathyroid gland transplants may prevent untreatable form of bone loss

Parathyroid gland transplants may prevent untreatable form of bone loss

Book on pediatric bone disorders and mineral metabolism

Book on pediatric bone disorders and mineral metabolism

Enobia Pharma's clinical study of ENB-0040 for treating hypophosphatasia provides positive results

Enobia Pharma's clinical study of ENB-0040 for treating hypophosphatasia provides positive results

Many patients in intensive care are deficient in vitamin D

Many patients in intensive care are deficient in vitamin D